drugset / Trial / NCT03023553
The Human Mucosal Immune Responses to Influenza Virus (SLVP026)
Phase 4
Completed
13 enrolled
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID) · collab
Non-randomizedParallel-groupOpen-labelBasic science
Summary
This study will examine the immune responses to the seasonal influenza vaccine in single cells of the nasal passages when compared with cells in circulating blood.
Timeline
- Start
- 2012-12
- Primary completion
- 2013-02
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FluMist | Vaccine | — | Intranasal |
| Subject | Fluzone | Vaccine | — | Intramuscular |